Live Breaking News & Updates on Sab Biotherapeutics|Page 4
Stay updated with breaking news from Sab biotherapeutics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
SAB Biotherapeutics, Inc. (NASDAQ:SABS – Get Free Report) saw a large decrease in short interest in September. As of September 15th, there was short interest totalling 306,500 shares, a decrease of 17.5% from the August 31st total of 371,600 shares. Based on an average daily volume of 35,900 shares, the short-interest ratio is presently 8.5 […] ....
SAB Biotherapeutics (NASDAQ:SABS – Get Free Report) announced its earnings results on Friday. The company reported ($0.14) earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of ($0.14), Yahoo Finance reports. SAB Biotherapeutics had a negative net margin of 213.54% and a negative return on equity of 87.92%. SAB Biotherapeutics Stock Performance Shares […] ....
SAB Biotherapeutics, Inc. (NASDAQ:SABS – Get Free Report) was the recipient of a large growth in short interest in the month of June. As of June 30th, there was short interest totalling 463,200 shares, a growth of 27.1% from the June 15th total of 364,300 shares. Based on an average daily trading volume, of 1,340,000 […] ....
SAB Biotherapeutics, Inc. (NASDAQ:SABS – Get Rating) saw a large drop in short interest during the month of May. As of May 31st, there was short interest totalling 428,100 shares, a drop of 35.7% from the May 15th total of 665,400 shares. Based on an average trading volume of 1,320,000 shares, the days-to-cover ratio is […] ....
SAB Biotherapeutics, Inc. (NASDAQ:SABSW – Get Rating) was the recipient of a large decrease in short interest in the month of May. As of May 31st, there was short interest totalling 8,500 shares, a decrease of 50.0% from the May 15th total of 17,000 shares. Based on an average daily volume of 25,900 shares, the […] ....